What is it?
The most beneficial and the only proven intervention for selective patients with an acute ischemic stroke is thrombolytic therapy with intravenous tissue plasminogen activator (tPA) medicine, which breaks up or dissolves blood clots.
For a patient with an ischemic stroke, intravenous tPA must be administered promptly, within four and a half hours of when symptoms begin. They are delivered though an IV and can dissolve clots, restore blood flow and limit damage.
The Loyola difference
For the fifth year in a row, Loyola University Medical Center has won the Get with the Guidelines® - Stroke Gold Plus Quality Achievement Award from the American Heart Association. U.S. News & World Report also ranked us as a high-performing hospital in Neurology and Neurosurgery. Loyola has been certified by the Joint Commission as an Advanced Primary Stroke Center.